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Purpose
Abstract In a daily clinical practice, glomerular filtration rate (GFR) is still estimated on the basis of short MDRD formula, 
whereas medications’ Summaries of Product Characteristics suggest that GFR used for the dosage adjustment should be 
estimated based on the Cockcroft–Gault (C–G) equation. The aim of the study was to compare eGFR values calculated on 
the basis of short and full MDRD and C–G equations in PolSenior study participants with decreased eGFR.
Methods We have assessed differences in the estimation of GFR between short and full MDRD, as well as C–G formula, all 
equations utilizing non-isotope-dilution mass spectrometry-calibrated measurements of serum creatinine, in the community-
based population of 760 persons aged 65 years or above (mean age 82 ± 8 years) with estimated GFR < 60 ml/min/1.73 m2 
(according to short MDRD). In addition, in our analysis, we have included the detailed characteristics of comorbidities and 
different aspects of mobility and functional performance.
Results The better concordance, precision, and accuracy with MDRD short formula were found for  MDRDfull than C–G 
equation. In logistic regression analysis, female gender, activities in daily living (ADL) ≤ 4, and age > 80 years diminished, 
while visceral obesity improved accuracy  (P30) of eGFR calculated according to C–G equation as compared to  MDRDshort. 
Similar analysis did not found factors influencing  P30 for  MDRDfull equation.
Conclusions In very old subjects, especially females, dependent patients and those with visceral obesity, estimation of GFR 
based on short MDRD formula should not be used interchangeably with Cockcroft–Gault equation for the medicines dose 
tailoring.
Keywords Activities of daily living · Age · Drug dosage · Older patients · Gender · Glomerular filtration rate
Introduction
The accurate estimation of renal function in older patients 
remains a serious challenge. For many years, the estima-
tion was based on the Cockcroft–Gault (C–G) formula [1], 
regardless of noticeable limitations [2]. To mention just 
a few, the C–G formula underestimates GFR in slim and 
overestimates GFR in obese older patients [3]. Low muscle 
mass (sarcopenia) and decreased daily creatinine produc-
tion explains the bias in GFR estimation [4]. In addition, 
it should be stressed that the C–G formula has never been 
validated in an older population. A newer equation, the 
MDRD formula, was introduced in late 1990s as a result 
of Modification of Diet in Renal Disease study analysis [5] 
and has gained worldwide acceptance, especially its sim-
plified, short version including only demographic variables 
and serum creatinine levels. This formula has enabled an 
automatic calculation of GFR in all laboratories performing 
basic serum creatinine measurement. Of note, more recent 
guidelines [6] suggest the use of creatinine-based CKD-EPI 
equation that requires serum creatinine measurement using 
specific assays with calibration traceable to the isotope-
dilution mass spectrometry (IDMS). The same is true for 
a dedicated older Berlin Initiative Study 1 equation (BIS1) 
[7]. However, the availability of IDMS-calibrated assays in 
daily clinical practice is still limited. The rising gap between 
recommendations and daily clinical practice is further puz-
zled by requirements of pharmacotherapy [8]. According to 
medications’ Summaries of Product Characteristics, GFR 
used for the dosage adjustment should be estimated based 
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on the C–G equation. However, laboratory platforms auto-
matically calculate GFR, usually based on MDRD formula, 
and listed this value in the laboratory reports, while C–G 
creatinine clearance has to be calculated manually by the 
physician. This procedure increases the risk of inappropriate 
drug dosing in older patients.
The aim of this study was to assess the clinical factors, 
including patients’ comorbidity and functional performance 
measures, which may increase the incompatibility of renal 
function assessment with MDRD or Cockcroft–Gault equa-
tions in old individuals.
Methods
Study design and setting
The study protocol complied with the Declaration of Hel-
sinki regarding ethical conduct of research involving human 
subjects and was approved by the Bioethics Committee of 
Medical University of Silesia in Katowice. All participants 
gave their informed consent. Serum samples used for the 
assessment of serum creatinine in the presented study were 
obtained from participants of the PolSenior study—a large, 
cross-sectional, multicenter, interdisciplinary, publicly 
funded research project, focused on older people, con-
ducted in Poland from 2007 to 2011. The study design was 
described elsewhere [9]. The eGFR values were available 
in 1906 respondents aged 65–80 years and 1592 above the 
age of 80 years.
Only participants with eGFR < 60  ml/min/1.73  m2 
(according to short MDRD) were included in the current 
analysis.
Laboratory measurements
Serum and urine creatinine concentrations were assessed 
using Jaffe method, serum urea by kinetic UV method, and 
serum albumin by colorimetric method (Modular PPE, 
Roche Diagnostics GmbH, Mannheim, Germany).
Urinalysis was performed initially with the strip method 
(Combur-Test) with urinary albumin quantification using 
Miditron M system (Roche Diagnostics GmbH, Man-
nheim, Germany). In subjects in whom albuminuria was 
not detected with this method (< 300 mg/l), high sensitivity 
(< 3 mg/l) immunoturbidimetric method was used (Roche 
Diagnostics GmbH, Mannheim, Germany). Urine albumin-
to-creatinine ratio (UACR) was calculated.
Serum C-reactive protein concentrations were assessed 
by an automated system (Modular PPE, Roche Diagnostics 
GmbH, Mannheim, Germany) with intermediate precision 
below 5.7%.
Serum N-terminal prohormone for brain natriuretic pep-
tide (NT-proBNP) was assessed using the electrochemilu-
minescence method on Cobas E411 analyzer (Roche Diag-
nostics GmbH, Mannheim, Germany) with intermediate 
precision below 4.6%.
Data analysis
Renal function was estimated using short MDRD, full 
MDRD [5], and Cockcroft–Gault [1] equations. We used 
eGFR values for short MDRD formula to score CKD stages 
as recommended by KDIGO [6].
Obesity and visceral obesity were classified according to 
the WHO and IDF criteria [10, 11].
Diagnosis of diabetes was established based on medical 
history, medication, and fasting serum glucose concentration 
≥ 126 mg/dl.
Cardiovascular diseases included coronary artery disease 
and stroke diagnoses established on the basis of a question-
naire survey and medical history. Arterial hypertension was 
diagnosed based on home blood pressure measurements dur-
ing two visits, if the average systolic blood pressure was at 
least 140 mmHg and/or average diastolic blood pressure was 
at least 90 mmHg, or the subject reported receiving antihy-
pertensive medications.
Subjects with serum NT-proBNP concentration above 
2000 pg/ml were classified as having heart failure [12].
Assisted mobility was assessed on the basis of self-
reported data. Activities of daily living (ADL) were evalu-
ated on the basis of 6-item Katz index and the values ≤ 4 
were scored as dependence.
Relative bias of eGFR values (%) was calculated as a 
difference between values obtained using the analyzed for-
mulas and short MDRD equation value, expressed as the 
percentage of the latter.
Statistical analysis
Statistical analysis was performed using STATISTICA 13.1 
PL (StatSoft, Cracow, Poland), StataSE 12.0 (StataCorp LP, 
TX, USA), and R software. Statistical significance was set 
at a p value below 0.05. All tests were two-tailed. Imputa-
tions were not done for missing data. Nominal and ordinal 
data were expressed as percentages, whilst interval data were 
expressed as mean value ± standard deviation in the case of 
normal distribution or as median/interquartile range in the 
case of data with skewed or non-normal distribution. Dis-
tribution of variables was evaluated by the Shapiro–Wilk 
test and homogeneity of variances was assessed by the Lev-
ene test. For comparison of eGFR values between differ-
ent equations, the one-way ANOVA analysis was used with 
Tukey’s post hoc test. To assess the influence of gender and 
CKD groups to relative bias, the two-way ANOVA analysis 
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was used with contrast analysis. To assess the relationship 
between eGFR values calculated according to short MDRD 
equation and other formulas, the Passing–Bablok regression 
as well as the concordance correlation coefficient were used. 
Bias, precision, and accuracy were measured to determine 
the performance of each equation. Bias was calculated as 
a median difference with 95% confidence interval between 
short MDRD equation and other two formulas. Positive/
negative bias means that eGFR values calculated with any 
formula are overestimated/underestimated in comparison to 
eGFR values calculated based on short MDRD equation. 
Precision was assessed with as interquartile range (IQR) for 
the differences. Accuracy was measured as the percentage of 
estimates within 30% of short MDRD equation  (P30).
To identify factors affecting the relative bias of each 
eGFR equation, the least angle square regression was used, 
which provided estimate of standardized regression coef-
ficient β. Positive β of any significant variable, enclosed in 
the model, means that the relative bias increases, while the 
variable values increase, whereas negative β means that the 
relative bias decreases, while the variable values increase. 
Multivariable stepwise backward logistic regression was 
used to identify factors affecting accuracy. The course of 
the relative bias was shown with the distance-weighted least-
squares regression.
Results
Participants
Glomerular filtration rate values were estimated in 3498 
subjects (85.3% out of 4101 PolSenior study participants 
in whom the blood samples were obtained), 1658 females 
(719 aged more than 80 years), and 1840 males (873 aged 
more than 80 years). Of all, 760 participants (416 female 
and 344 male) had eGFR values below 60 ml/min/1.73 m2, 
as calculated with short MDRD formula, and were included 
in the present analysis (Table 1).
Comparison of eGFR values (relative bias)
The estimated slope and intercept of the Passing–Bablok 
regression analysis showing the relation between eGFR cal-
culated according to short MDRD formula and eGFR yielded 
by two other equations, in subjects with eGFR < 60 ml/
min/1.73 m2  (MDRDshort), are presented in Table 2. For 
both examined equations (full MDRD and C–G), the slope 
was significantly different from the value of 1.0. Moreover, 
there was a negative systematic difference in both equa-
tions. Larger difference was noted in case of C–G than in 
full MDRD equation.
Moreover, the concordance correlation coefficient ρc, 
which evaluates the degree to which pairs of observations 
fall on the 45° line through the origin, and, therefore, shown 
a level of agreement between two methods, was calculated. 
The higher value and thus the better concordance were 
obtained for full MDRD equation. In addition, bias as well 
as precision and accuracy were better in full MDRD equa-
tion in comparison to C–G equation.
Factors influencing the relative bias in GFR 
estimation
For participants with eGFR lower than 60 ml/min/1.73 m2 
 (MDRDshort), there was a significant influence of gender on 
the relative bias for full MDRD but not for the C–G equa-
tion. For full MDRD equation, men presented slightly, but 
significantly higher relative bias than women (Table 3). 
Significant differences in relative bias between particular 
CKD stages (G3a–G4) occurred only in case of full MDRD 
equation, with the relative bias increasing across CKD stages 
both in men and women (Table 3).
To identify factors affecting the relative bias of each 
eGFR equation, results of the least angle square regression 
Table 1  Study group characteristics’—PolSenior participants with 
eGFR values below 60 ml/min/1.73 m2 (calculated with short MDRD 
formula)
Mean ± standard deviation
BMI body mass index, ADL activities of daily living, Katz index, hs-
CRP high-sensitive C-reactive protein, UACR urine albumin-to-cre-
atinine ratio
All
N = 760
Men
N = 344
Women
N = 416
Age, year 82 ± 8 83 ± 8 82 ± 8
BMI, kg/m2 28.4 ± 5.0 27.4 ± 4.1 29.2 ± 5.5
Obesity, n (%) 237 (31.3) 72 (20.9) 165 (39.9)
Waist circumference, cm 99.0 ± 13.0 101.2 ± 12.0 97.2 ± 13.5
Visceral obesity, n (%) 643 (85.3) 265 (77.7) 378 (91.5)
Assisted mobility, n (%) 258 (33.9) 112 (32.6) 146 (35.1)
ADL ≤ 4, n (%) 89 (11.7) 37 (10.8) 52 (12.5)
Hypertension, n (%) 588 (77.7) 250 (73.1) 338 (81.4)
Type 2 diabetes, n (%) 207 (27.3) 86 (25.1) 121 (29.1)
Heart failure, n (%) 105 (13.9) 59 (17.3) 46 (11.1)
History of stroke, n (%) 87 (11.5) 39 (11.4) 48 (11.6)
hs-CRP ≥ 3 mg/L, n (%) 356 (46.9) 168 (49.0) 188 (45.2)
UACR ≥ 300 mg/g, n (%) 44 (5.8) 26 (7.6) 18 (4.3)
Kidney function estimates
 Short MDRD, ml/
min/1.73 m2
48.6 ± 8.8 48.9 ± 8.8 48.4 ± 8.8
 Full MDRD, ml/
min/1.73 m2
42.5 ± 8.2 42.7 ± 8.2 42.4 ± 8.2
 Cockcroft–Gault, ml/min 42.4 ± 13.8 42.3 ± 13.3 42.6 ± 14.2
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were used (Table 4). The coefficient values are yielded for 
the minimum estimation of prediction error Cp. For each 
analyzed equation, age over 80 years was the most important 
factor influencing the relative bias. Moreover, dependence 
in daily living, the occurrence of heart failure, and UACR 
≥ 300 mg/g were among the most important factors affect-
ing full MDRD equation, while the occurrence of visceral 
obesity, hypertension, and diabetes were the factors affecting 
the relative bias for C–G equation.
Logistic regression analysis, for the accuracy of eGFR 
calculated according to C–G equation as compared to 
 MDRDshort, showed that female gender, ADL ≤ 4, and age 
> 80 years were factors diminishing accuracy  (P30), while 
visceral obesity improved accuracy (Table 4).
Figure  1 presents the relative bias (%) for C–G and 
 MDRDfull equation across the whole eGFR range, calcu-
lated with short MDRD equation, and shown in separate 
charts for men and women, and for ≤ 80 and > 80 years age 
groups, respectively. The relative bias of full MDRD equa-
tion remained nearly constant across eGFR values and did 
not differ between all four subgroups. For the C–G equa-
tion, both in men and women ≤ 80 years, the relative bias 
was increasing with declining of eGFR to values around 
35 ml/min/1.73 m2 and then was diminishing, while, for 
older participants, the relative bias was decreasing con-
stantly with decreasing eGFR values (from value around 
50 ml/min/1.73 m2). Moreover, for participants ≤ 80 years, 
the relative bias tended to be positive, while for older 
ones—negative.
Discussion
In the present study, we have analyzed the differences in 
the estimation of GFR between the short MDRD formula 
and two other equations utilizing not-IDMS-calibrated 
measurements of serum creatinine in the older popula-
tion. As the possible clinical consequences of discrepan-
cies between eGFR values calculated with different for-
mulas are most relevant among patients with substantially 
diminished renal excretory function, we have focused on 
the subgroup of patients with short MDRD eGFR < 60 ml/
min/1.73 m2. Of importance, despite of comparable mean 
eGFR values in the whole-study group, calculated with 
two different formulas, e.g., the full MDRD and the C–G, 
the detailed analysis revealed that there were major rela-
tive bias size as well as changes of its sign, which yield 
differences between gender and age subgroups. The stage 
of CKD was another important factor modifying the rela-
tive bias of  MDRDfull equation, mostly in men. Moreo-
ver, comorbidity as well as the activities of daily living 
have further influenced the between-formula relative dif-
ferences. Of note, the particular importance of all those 
analyzed co-factors differed widely, depending on certain 
eGFR formula. Neglecting of those details when calculat-
ing eGFR value in daily clinical practice may lead to the 
significant error in the estimation of renal excretory func-
tion in an individual patient level and, in consequence, 
to the inadequate diagnosis and potentially inappropriate 
therapy.
Our observation regarding the serious inconsistency 
between an acceptable MDRD and C–G average concord-
ance with substantial differences at the individual level are in 
line with results of Pedone et al. [13], where only diagnosis 
of severe CKD (eGFR < 30 ml/min/1.73 m2) in older patients 
showed a fair agreement of two compared formulas, and the 
magnitude of the differences in GFR estimates was influ-
enced by age and weight. More recently, Evans et al. have 
noticed an inaccuracy of five different eGFR formulas in 
patients with eGFR < 30 ml/min/1.73 m2, especially in older 
patients and those with diabetic nephropathy [14]. They also 
observed the lowest accuracy of the C–G (approximately 
54%) [14]. Of note, in their study, the median bias was stable 
across measured GFR categories, whereas, in our study, the 
relative bias variability was significant regarding full MDRD 
equation. However, in a subgroup of patients over 65 years 
[14], the relative accuracy of all analyzed formulas except 
the C–G was inferior as compared to younger subjects.
When comparing the non-IDMS traceable eGFR formu-
las with the CKD-EPI equation, Bevc et al. demonstrated 
Table 2  Results of the Passing–Bablok regression, bias, precision, and accuracy between eGFR calculated according to C–G and  MDRDfull 
equations, and concordance correlation coefficients in subjects with eGFR < 60 ml/min/1.73 m2 according to short MDRD
IQR interquartile range, C–G Cockcroft–Gault, MDRD modification of diet in renal disease formula
Equation Intercept (± 95% CI) Slope (± 95% CI) Residual standard 
deviation (± 95% CI)
Concordance coef-
ficient ρc (± 95% CI)
Bias median 
difference
Precision IQR Accuracy  P30
Systematic difference Proportional dif-
ference
Random difference (± 95% CI) (± 95% CI) (± 95% CI)
C–G − 45.93 (− 54.32– 
to  38.58)
1.79 (1.65–1.97) 6.70 (− 13.13–13.13) 0.455 (0.410–0.498) − 6.79 (− 7.61 to 
− 5.86)
15.19 (13.92–16.46) 70.3 (66.9–73.4)
MDRDfull − 3.03 (− 3.94 to 
− 2.17)
0.94 (0.92–0.96) 1.70 (− 3.33–3.33) 0.762 (0.741–0.782) − 5.94 (− 6.19 to 
− 5.72)
3.26 (2.98–3.54) 99.9 (99.3–100.0)
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that the accuracy within 30% of estimated 51Cr-EDTA 
clearance values differs according to the stage of CKD [15]. 
Moreover, they have validated a simple cystatin C formula 
as a reliable marker of GFR in older persons, comparable to 
other formulas, including MDRD and CKD-EPI formulas. 
Importantly, in a recent study, Kilbride et al. have found 
the accuracy of short MDRD equation inferior to the CKD-
EPI only in older patients with measured GFR > 60 ml/
min/1.73 m2 [16]. Furthermore, in the very old population 
(mean age 85 years), the CKD-EPI and the Berlin Initiative 
Study (BIS) creatinine–cystatin C equations showed a bet-
ter accuracy than other equations in GFR estimation [17]. 
The best performance of the CKD-EPI creatinine–cystatin C 
equation in older people was also confirmed in community-
based AGES-Reykjavik Study [18]. In contrast, in the older 
Chinese cohort, the bias of the CKD-EPI creatinine–cystatin 
C equation was greater than with other equations, includ-
ing short MDRD equation [19]. Finally, the comparison of 
CKD-EPI and MDRD formulas in large cohort of nearly 
175,000 primary care patients showed that mean bias, 
although statistically significant at all age groups, dimin-
ished with age, from 13% in the 18–29 years age group to 
− 7.5% in those aged over 90 years [20]. Authors concluded 
that, at age over 70 years, there is very little difference 
between these two equations [20]. Of note, in a subset of 
very old subjects with measured GFR < 60 ml/min/1.73 m2, 
short MDRD equation was characterized by high specificity, 
comparable to CKD-EPIcreat [17].
To date, patients’ weight demonstrated a strong influence 
on the discrepancy between C–G and full MDRD formulas 
in one study [13]. Moreover, short MDRD and other equa-
tions’ accuracy were generally lower in patients with dia-
betic nephropathy [14]. Of importance, an essential aspect 
of our study is the detailed investigation of demographic 
and clinical factors, which could markedly influence eGFR 
values. Most of them, except for age, have not been included 
in the previous analyses. We would like to emphasize that 
apart from CKD, the older population is characterized by 
high comorbidity and large proportion of disabled persons. 
It is of particular importance that some of these conditions 
may substantially change the GFR estimation and, in con-
sequence, cause an inappropriate adjustment of medication 
dosage in such patients. In our study, age, the presence of 
heart failure, and UACR ≥ 300 mg/g were among the most 
important factors affecting the relative bias for full MDRD 
equation, while the occurrence of age and visceral obesity 
was the factors affecting the relative bias for C–G equation. 
Of note, multivariable logistic regression analysis confirmed 
the independent influence of age over 80 years, visceral 
obesity, and female gender on the C–G equation accuracy, 
while any for full MDRD equation. The unexpected effect 
of visceral obesity on the relative bias between C–G and 
 MDRDshort equations is probably a consequence of the effect Ta
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Table 4  Results of the least 
angle square regression for 
the relative difference in 
eGFR values (left panel) 
and multivariable stepwise 
backward logistic regression for 
P30 inaccuracy (right panel), 
calculated according to short 
MDRD equation, the coefficient 
values for the minimum 
estimation of prediction error 
Cp, accordance of eGFR < 60 
between short MDRD and C–G 
and  MDRDfull equation
Left panel: superscript indexes show actions along the sequence of models (1 means the strongest effect). 
Right panel: P30: difference to group without disease as a baseline
Hs-CRP high-sensitive C-reactive protein, ADL Independence in Activity of Daily Living index, UACR 
urine albumin-to-creatinine ratio
*p < 0.05; **p <  0.01; #p < 0.001
Variable LARS regression for eGFR differ-
ences
Logistic regression for P30 inaccu-
racy OR (± 95% CI)
C–G MDRDfull C–G MDRDfull
Diabetes 0.07993 – – –
Heart failure − 0.00578 − 0.00782 – –
Hypertension 0.03664 0.00505 – –
History of stroke 0.004710 0.00657 – –
Visceral obesity 0.16632 0.00496 4.51# (2.81–7.22) –
hs-CRP ≥ 3 0.01857 − 0.00208 – –
Assisted mobility − 0.01019 0.00634 – –
Age > 80 years − 0.26851 − 0.01411 0.21# (0.14–0.33) –
ADL ≤ 4 − 0.03835 – 0.60* (0.37–0.99) –
Female gender − 0.02996 – 0.46# (0.32–0.67) –
UACR ≥ 300 mg/g – − 0.02493 – –
Fig. 1  Relative bias (%) for each eGFR equation across eGFR calculated with short MDRD formula
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of greater body mass in some very old individuals, result-
ing in higher calculated values according to C–G formula, 
that diminish the influence of age, with no effect on eGFR 
computed with  MDRDshort formula.
Summarizing the results, we may assume that the inter-
pretation of eGFR values calculated according to the C–G 
formula should be cautious, especially in the very old female 
population, as age and gender consist of the main factors 
causing the substantial bias of C–G formula, with severe 
sarcopenia as a possible explanation. Moreover, as a simi-
lar MDRD and CKD-EPI formulas’ performance was noted 
within the most clinically relevant GFR range, i.e., below 
60 ml/min/1.73 m2 [14, 15, 17], with the only exception for 
formulas based on simultaneous creatinine and cystatin C 
determination, and keeping in mind the cost-effectiveness 
issues, the GFR estimation in daily clinical practice may 
be still reliably calculated using the short MDRD equation. 
However, in case of GFR estimation for individual drug dos-
age adjustment, short MDRD formula should not be used 
interchangeably with C–G formula, and we should keep in 
mind patient’s comorbidity as an important factor influenc-
ing the accuracy of GFR estimation.
The present study has some limitations. As previously 
mentioned, we were unable to calculate the bias between 
short MDRD formula and currently recommended by 
KDIGO CKD-EPI equation, as serum creatinine in the ana-
lyzed cohort was not measured by a method calibrated to 
IDMS. Even more important limitation is related to the lack 
of clearance-measured GFR. However, this method is not 
readily applicable in population-based epidemiological stud-
ies. Another limitation is caused by the fact that analyzed 
data were partially obtained via questionnaire. Finally, some 
selection bias may be related to the proportionally higher 
rate of exclusion among very old participants who were not 
able to get into the vertical position needed for measurement 
of body weight.
Strengths of our study include the detailed characteristics 
of comorbidities and different aspects of mobility and func-
tional performance, rarely analyzed in other studies. Moreo-
ver, using of the Passing–Bablok regression, the least angle 
square regression as well as the distance-weighted least-
squares regression ensure reliable statistical analysis which 
is in line with the latest guidelines.
Conclusions
Taking into account that Summaries of Product Charac-
teristics of many medicines still refer to Cockcroft–Gault 
formula, whereas laboratories worldwide calculate and 
report the  MDRDshort-based eGFR values, there is a serious 
inconsistency with possible life-threatening consequences. 
As our study showed, GFR estimated with  MDRDshort and 
Cockcroft–Gault formulas should not be used interchange-
ably in very old people, especially in females, as well as in 
dependent patients and subjects with visceral obesity. Thus, 
the drug dosing adjustment in older patients should not be 
based on eGFR values routinely reported by local laborato-
ries, but should be calculated according to the reference, i.e., 
the Cockcroft–Gault equation.
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